RECRUITING

Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree

Talk to us

Conditions

Open Angle Glaucoma

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study to optimize Selective Laser Trabeculoplasty (SLT) application when used in the management of open angle glaucoma (OAG)

Official Title

Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree

Quick Facts

Study Start:2025-01-06
Study Completion:2025-12-17
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06851546

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years and older
  2. * Ability to comprehend the study procedures and agreement to proceed with primary SLT treatment
  3. * Diagnosis of primary or secondary open angle glaucoma or glaucoma suspects with ocular hypertension
  4. * Bilateral disease
  5. * Pre-SLT IOP \>21 mmHg measured at least twice during patient's lifetime with or without medication
  6. * Open angles with moderate to intense trabecular pigmentation
  7. * Mild to moderate visual field defects (24-2 standard mean deviations better than the Swedish interactive thresholding algorithm standard of 12 dB)
  8. * No adequate IOP control (low treatment compliance, substantial adverse effects with eyedrops, and at least 2 IOP measurements higher than the individualized target IOP)
  1. * Unwilling or unable to give consent
  2. * Unable to attend scheduled post-operative visits
  3. * Previous history of either laser treatment or intraocular surgery, except for non-complicated cataract surgery (performed \>6 months before SLT)
  4. * History of ocular trauma
  5. * Narrow angles
  6. * Retinal detachment
  7. * Active iris neovascularization or active proliferative retinopathy
  8. * Active uveitis
  9. * Monocular patients
  10. * Current use of steroids (ocular, periocular, or systemic)

Contacts and Locations

Study Contact

Rami Darwich, MD, PhD
CONTACT
507-284-2787
Darwich.Rami@mayo.edu

Principal Investigator

Arthur Sit
PRINCIPAL_INVESTIGATOR
Mayo Clinic

Study Locations (Sites)

Mayo Clinic in Rochester
Rochester, Minnesota, 55905
United States

Collaborators and Investigators

Sponsor: Mayo Clinic

  • Arthur Sit, PRINCIPAL_INVESTIGATOR, Mayo Clinic

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-01-06
Study Completion Date2025-12-17

Study Record Updates

Study Start Date2025-01-06
Study Completion Date2025-12-17

Terms related to this study

Additional Relevant MeSH Terms

  • Open Angle Glaucoma